首页> 外文会议>International Symposium on Hormonal Carcinogenesis >Estrogen-Induced Mutations and Its Role in the Development of Tumorigenesis
【24h】

Estrogen-Induced Mutations and Its Role in the Development of Tumorigenesis

机译:雌激素诱导的突变及其在肿瘤发生发展中的作用

获取原文

摘要

Using RAPD-PCR fingerprinting, the detection of mutations induced by estrogen (E) exposure was studied in nonmalignant- and malignant cells. Cells exposed to 17a-and 173-estradiol, diethylstilbestrol, bisphenol A, and a-zearalanol induced mutations in different regions of the genome. They consisted of insertion/deletion as a result of point or length mutations and quantitative changes as a result of hypoploidy or polyploidy. We also detected several mutated loci in tumor-free tissues, adjacent to tumors, and DES-induced tumors. The data suggest that these mutations occurred in early stages of stilbene E-induced renal carcinogenesis, and that they may be induced as a result of stilbene E treatment.
机译:使用RAPD-PCR指纹识别,在非开始和恶性细胞中研究了雌激素(E)曝光诱导的突变的检测。暴露于17A和173-雌二醇,二乙基苯乙醇,双酚A和A- Zearalanol的诱导在基因组的不同区域中的突变。它们由插入/缺失组成,由于点或长度突变,并且由于Hyppropody或多倍体的定量变化。我们还在无肿瘤组织中检测到几个突变的基因座,邻近肿瘤和DES诱导的肿瘤。该数据表明,这些突变发生在斯蒂替酯E-肾癌发生的早期阶段,并且它们可以作为硅烯E处理诱导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号